Men's Health

Britt DM, Kubin M, Keininger D, Trudeau E, Sagnier P, Fugl-Meyer A. Development and validation of the treatment satisfaction scale (TSS) for erectile dysfunction. Poster presented at the 2nd International Consultation on Erectile and Sexual Dysfunctions; June 2003.

Abstract not available at this time

Baldus T, Nehra A, Brock G, Britt DM. Influence of vardenafil, a potent, highly selective phosphodiesterase-5 inhibitor on improving erectile function and depressive symptomatology in patients with erectile dysfunction secondary to radical nerve-sparing prostatectomy. Poster presented at the 31st Annual Meeting of the American Academy of Physician Assistants; May 2003.

Abstract not available at this time

West SL, Dever JA, Troutman KS, Gilsenan AW, Glasser D. Methodology for conducting a national population-based prevalence study of erectile dysfunction. Poster presented at the 18th International Conference on Pharmacoepidemiology; 2002.

Abstract not available at this time

DiBenedetti DB, Gondek K, Sagnier PP, Kubin M, Keininger D, Marquis P. The treatment satisfaction scale: a multidimensional instrument for the assessment of treatment satisfaction for erectile dysfunction patients and their partners. Eur Urol. 2005 Sep 1;48(3):503-11.

BACKGROUND: The development of the Treatment Satisfaction Scale (TSS) was previously reported (Kubin et al., 2004).

 

OBJECTIVE: This article describes the psychometric validation process and psychometric properties (e.g., reliability, validity, and responsiveness) of TSS.

 

METHODS: Initial patient and partner questionnaires were administered in a multi-national clinical trial.

Malcoe LH, Midkiff KD, Damphousse K. Context and motives for women's and men's use of violence in intimate relationships. Poster presented at the American Society of Criminology Annual Meeting; November 2001.

Abstract not available at this time

Mast TC, DeMuro-Mercon CJ, Granger AL, Santanello N, Huyett J, Goldstone S. The psychosocial impact of human papilloma virus (HPV) and related interventions among heterosexual men (HSM) and men who have sex with men (MSM). Poster presented at the 21st International Papillomavirus Conference; February 2004.

Abstract not available at this time

Chen L, Candrilli SD. Age-segmented rates of treatment, goal attainment, comorbidities and lifestyle risks among men diagnosed with hypertension and dyslipidemia in the United States. Poster presented at the 2009 Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Conference; April 2009.

Abstract not available at this time

Trump DL, Wilding G, Miller K, Small E, Soulie P, Trachtenberg J, Raabe N, Heyes AE, Das-Gupta A. Pilot trials of ZD1839 ('Iressa'), an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor, in combination with mitoxantrone/prednisolone or docetaxel/estramustine in patients with hormone-refractory prostate cancer. Presented at the American Urology Association; April 2003. Chicago, IL.

Abstract not available at this time

Poulos C, Levin C, Hoang V, Yang J, Nguyen D. Mothers' and fathers' private demand for HPV vaccines in Viet Nam. Poster presented at the 7th World Congress on Health Economics: Harmonizing Health and Economics; July 2009.

Abstract not available at this time

Naslund M, Gilsenan AW, Midkiff KD, Wolford E, Bown A, Wang J. The prevalence of luts and prostate enlargement in the primary care setting. Poster presented at the Annual Meeting of the American Urological Association; 2007.

Abstract not available at this time

Subscribe to Men's Health

How Can We Help You?